A 14-year-old going through puberty. In the medical world, that's called "Tuesday." But at Children's Hospital of Philadelphia, Boston Children's Hospital, and clinics across the country, doctors were typing a different code into the billing system — E301, Central Precocious Puberty — and submitting claims for drugs to stop it.
The puberty wasn't early. The diagnosis was fake. The insurance payouts were very real.
The Department of Health and Human Services dropped a report this week titled "Wolves in White Coats," and the name earns itself inside of two pages. Federal investigators found that nearly $120 million in pediatric gender procedures have been billed since 2019 — including more than 5,500 surgeries ranging from $12,000 to $130,000 each and roughly 8,500 courses of puberty blockers and cross-sex hormones running $600 to $16,000 per year.
The fraud mechanism is elegant in its brazenness. Insurers won't cover puberty blockers prescribed for gender dysphoria in minors in many states. So providers diagnosed kids with "endocrine disorder, unspecified" — billing code E34.9 — or tagged teenagers with "precocious puberty," a condition that by medical definition occurs before age 8 in girls and age 9 in boys. A University of Iowa study found that fewer than 5% of patients coded with "unspecified endocrine disorder" actually had an endocrine condition.
The numbers tell the story better than any editorial could. Nearly $50 million was billed between 2015 and 2025 for puberty blockers administered to patients ages 9 through 17 under endocrine disorder diagnoses. Of that, $11 million went specifically to blockers for kids ages 13 to 17 who were diagnosed with precocious puberty — a biological impossibility at that age.
Pennsylvania's data is particularly grotesque. Precocious puberty reimbursements through the state's Medical Assistance program surged 2,100% between 2013 and 2017. Between 2020 and 2024, Pennsylvania processed 1,900 blocker claims for children ages 10 to 13 and another 1,000 claims for kids 14 to 18. Boston Children's Hospital recorded zero Central Precocious Puberty diagnoses from 2017 to 2019. By 2022, they had 50 in a single year. CHOP diagnosed more than 250 minors age 10 and older — including numerous cases involving kids 14 to 18 — with a condition that, again, ends before age 9.
The HHS executive summary put it plainly: "The expansion of pediatric sex-rejecting procedures resulted from an interaction among financial incentives, potentially illegal billing practices" and ideological capture of medical institutions. HHS Secretary Robert F. Kennedy Jr. and Assistant Secretary of Health Brian Christine oversaw the investigation, which also referenced the case of Dr. Eithan Haim, the surgeon and whistleblower who first raised alarms about Texas Children's Hospital's gender program.
Soren Aldaco, a detransitioner and ambassador for the Independent Women's Forum, described what this system produced on the patient side: "Young people led deeper into their problems instead of out of them."
The professional organizations that were supposed to prevent this — WPATH, the Endocrine Society, the American Academy of Pediatrics — spent years building the clinical frameworks that made the billing fraud possible. They wrote the guidelines. They endorsed the diagnoses. They created the market. When Attorney General Todd Blanche's DOJ and HHS investigators started pulling billing records, what they found wasn't a few bad actors. It was an industry.
The Trump administration has already cut off Medicaid and CHIP funding for these procedures on minors. Detransitioners like Clementine Breen and Layla Jane — formerly Kayla Lovdahl — are pursuing legal action.
A $120 million billing apparatus. Fake diagnoses entered into children's medical records. Professional societies providing institutional cover. Insurance companies paying claims for conditions that don't exist at the ages being billed.
In most industries, that's called a fraud scheme. In pediatric medicine, it was called "best practices" — until somebody bothered to check the codes.